NASDAQ:SGEN
Delisted
Seattle Genetics Stock News
$228.74
+0 (+0%)
At Close: Mar 12, 2024
Pfizer offers $43 billion to buy cancer drugmaker Seagen
03:24pm, Monday, 13'th Mar 2023
CNBC's Meg Tirrell joins 'Power Lunch' to discuss Pfizer's acquisition of Seagen, the reasoning behind the $43 billion biotech deal, and more.
Pfizer CEO says it will be able to deliver Seagen's cancer therapy at a scale not seen before with $43 billion deal
01:48pm, Monday, 13'th Mar 2023
Pfizer CEO Albert Bourla said it will deliver Seagen's cancer therapy to the world at a scale that hasn't been seen before with its $43 billion acquisition.
Pfizer Overpays for Seagen, but Who's Counting
01:37pm, Monday, 13'th Mar 2023
Acquiring top biotech assets as other big pharmaceutical companies face a patent cliff was bound to be expensive.
Seagen has one of the greatest technologies to battle cancer: Pfizer CEO on acquisition
12:25pm, Monday, 13'th Mar 2023
Albert Bourla, Pfizer CEO, joins 'Squawk on the Street' to discuss his thoughts on the company buying Seagen.
Pfizer Buying Seagen For $43 Billion: Details (PFE) (SGEN)
12:09pm, Monday, 13'th Mar 2023
Pfizer (NYSE: PFE) is buying Seagen Inc. (Nasdaq: SGEN) for $43 billion. These are the details.
Pfizer to pay $43B for Seagen, boosting cancer drug portfolio
11:58am, Monday, 13'th Mar 2023
The latest deal comes as Pfizer seeks to mitigate an anticipated $17 billion hit to revenue by 2030 from patent expirations for top drugs and decline in demand for its COVID products.
Why Seagen Stock Is Soaring Today
11:48am, Monday, 13'th Mar 2023
Pfizer plans to acquire Seagen for around $43 billion. Investors appear to have already been betting the deal would happen after several weeks of rumors about a potential buyout.
Seagen Stock Boosted on Billion-Dollar Buyout
11:41am, Monday, 13'th Mar 2023
Seagen Inc (NASDAQ:SGEN) stock is soaring today, after news that Pfizer (PFE) is acquiring the company for roughly $43 billion, expanding its access to cancer treatment.
Pfizer aiming to acquire Seagen in $43 billion deal
11:37am, Monday, 13'th Mar 2023
Yahoo Finance Live's Julie Hyman discusses reports that Pfizer is aiming to acquire Seagen in a $43 billion deal.
Regional banks pace decliners, as biotech deals lift Seagen and Provention Bio
11:17am, Monday, 13'th Mar 2023
Here are some of the biggest movers on Monday with banks firmly in focus after federal regulators stepped into protect deposits at fallen bank SVB.
SGEN Stock Alert: Pfizer Buys Seagen in GIANT $43 Billion Deal
11:15am, Monday, 13'th Mar 2023
Seagen (NASDAQ: SGEN ) stock is taking off on Monday as investors react to an acquisition deal with Pfizer (NYSE: PFE ). Pfizer is acquiring Seagen for $43 billion in cash.
Pfizer Officially Nabs Seagen For $43 Billion; Provention Soars On Sanofi Deal
09:17am, Monday, 13'th Mar 2023
Pfizer will buy Seagen for roughly $43 billion, and Sanofi will buy Provention for $2.9 billion. SGEN stock and PRVB stock soared.
Pfizer to purchase Seagen in $43 billion all-cash deal, cancer biotech's stock pops 20%
07:04am, Monday, 13'th Mar 2023
Pfizer Inc. PFE, -0.18% plans to acquire cancer biotechnology company Seagen Inc. SGEN, -0.59% in a deal with a $43 billion enterprise value, the companies announced Monday morning. Pfizer intends to
Hot Stocks And Hot Wings Serve Up Spicy Breakouts And Buy Zones
08:00am, Wednesday, 08'th Mar 2023
As the market indexes fight for support, ANET, WING, BKNG, CDNS, PANW and more land a spot on the IBD Breakout Stocks Index. The post Hot Stocks And Hot Wings Serve Up Spicy Breakouts And Buy Zones ap
The 5 Best and Worst Performing Large-Cap Stocks in February 2023
10:54pm, Tuesday, 07'th Mar 2023
Investing in large-cap stocks is considered one of the best ways to invest in the stock market.
